As of 2025-06-04, the Fair Value of Vaxil Bio Ltd (VXL.V) is -1.62 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.27 CAD, the upside of Vaxil Bio Ltd is -712.86%.
With the market price of 0.27 CAD and our fair value calculation, Vaxil Bio Ltd (VXL.V) is not a good investment. Investing in VXL.V stocks now will result in a potential loss of 712.86%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -1.36 | -0.99 | -0.58 | -0.25 | -0.18 | -0.67 |
| YoY growth | -17.68% | 27.39% | 40.77% | 56.51% | 29.92% | 27.38% |
| Market Cap (mil) | 0.73 |
| P/E | |
| Forward P/E |
| EPS | -0.06 |
| Avg earnings growth rate | 27.38% |
| TTM earnings | -0.18 |